Stocks and Investing Stocks and Investing
Mon, April 20, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Eric Wold Upgraded (AMC) to Hold on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Jerry Revich Upgraded (ALSN) to Strong Buy and Held Target at $44 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Tobey Sommer Maintained (BCO) at Strong Buy with Decreased Target to $80 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Elizabeth Suzuki Maintained (AZO) at Hold on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Gavin Parsons Downgraded (BAH) to Hold and Decreased Target to $79 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Doug Leggate Maintained (APA) at Strong Buy with Increased Target to $22 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Mark Kelley Maintained (ANGI) at Hold with Decreased Target to $7 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Stephen Biggar Upgraded (C) to Strong Buy on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Brett Levy Maintained (CBRL) at Hold with Decreased Target to $82 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Ben Herbert Maintained (CBOE) at Strong Buy with Increased Target to $112 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Stephen Tusa Initiated (CARR) at Buy and Held Target at $20 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Amit Daryanani Initiated (AKAM) at Buy and Held Target at $120 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Samir Khanal Upgraded (BRX) to Buy and Decreased Target to $13 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Doug Leggate Maintained (XOM) at Strong Buy with Increased Target to $70 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Robin Farley Maintained (CCL) at Hold with Decreased Target to $13 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Greg Gordon Downgraded (CNP) to Hold and Decreased Target to $17 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Jerry Revich Downgraded (TEX) to Hold and Held Target at $19 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Jeffrey Silber Maintained (TBI) at Hold with Decreased Target to $15 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Patrick Donnelly Maintained (TECH) at Hold with Increased Target to $54 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Simeon Gutman Maintained (ULTA) at Hold with Decreased Target to $215 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Justin Post Reiterated (SNAP) at Strong Buy with Increased Target to $15 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Stephen Ju Maintained (SNAP) at Buy with Decreased Target to $20 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Neal Dingmann Maintained (SM) at Hold with Decreased Target to $2 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Mathieu Robilliard Upgraded (VSAT) to Hold and Decreased Target to $53 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Ben Herbert Maintained (VIRT) at Hold with Increased Target to $24 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Alethia Young Reiterated (ASND) at Buy with Increased Target to $201 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Leland Gershell Maintained (ASND) at Buy with Increased Target to $219 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Adam Walsh Maintained (ASND) at Strong Buy with Increased Target to $171 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Tiago Fauth Maintained (ASND) at Buy with Increased Target to $149 on, Apr 20th, 2020
[ Mon, Apr 20th 2020 ] - WOPRAI
Joseph Schwartz Maintained (ASND) at Buy with Increased Target to $170 on, Apr 20th, 2020

Joseph Schwartz Maintained (ASND) at Buy with Increased Target to $170 on, Apr 20th, 2020


Published on 2024-10-27 03:28:24 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $152 to $170 on, Apr 20th, 2020.

Joseph has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph

  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $180 on, Thursday, April 2nd, 2020
Contributing Sources